A Pharmacokinetics and Safety Study of Narfurine Hydrochloride Orally Disintegrating Tablets

Improvement of Pruritus in Hemodialysis Patients Clinical Trial

Official title: A Single-center Phase I Clinical Study Evaluating the Pharmacokinetics and Safety of Single and Multiple Oral Administration of Narfurine Hydrochloride Orally Disintegrating Tablets in Chinese Healthy Adult Subjects

Status Active, not recruiting

Clinical Trial Summary

Main objective: To evaluate the pharmacokinetics of single and multiple oral administration of narfurine hydrochloride orally disintegrating tablets in Chinese healthy adult subjects.

Secondary objective: To evaluate the safety profile of single and multiple oral administration of narfurine hydrochloride orally disintegrating tablets in Chinese healthy adult subjects.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Improvement of Pruritus in Hemodialysis Patients
• Pruritus

• NCT number: NCT04420234
• Study type: Interventional
• Source: First Affiliated Hospital of Zhejiang University
• Status: Active, not recruiting
• Phase: Phase 1
• Start date: June 9, 2020
• Completion date: December 2020